COMMAND

EPOS and Aston Martin Aramco Cognizant Formula One® Team Strengthen Global Audio Partnership

Retrieved on: 
Thursday, December 7, 2023
Aston, ATC, COMMAND, Sound, Air traffic control, Formula, EPOS, Mission control center, Rain, Partnership, Communication, Noise, Environment, Management, C3

COPENHAGEN, Denmark, Dec. 7, 2023 /PRNewswire/ -- EPOS, today announces an extension and expansion of its partnership with the Aston Martin Aramco Cognizant F1® Team as Global Audio Partner.

Key Points: 
  • COPENHAGEN, Denmark, Dec. 7, 2023 /PRNewswire/ -- EPOS, today announces an extension and expansion of its partnership with the Aston Martin Aramco Cognizant F1® Team as Global Audio Partner.
  • Building on the existing collaboration, EPOS is expanding its technical partnership with the team.
  • "We moved the whole team into our new AMR Technology Campus in the spring, and it has been a significant positive change for the entire organization," said Mike Krack, Team Principal for the Aston Martin Aramco Cognizant Formula One® Team.
  • EPOS President, Jeppe Dalberg-Larsen comments, "With a unified ambition for unleashing human potential via technology, innovation, and state-of-the-art engineering – our partnership with Aston Martin Aramco Cognizant Formula One® Team is a natural fit.

EPOS and Aston Martin Aramco Cognizant Formula One® Team Strengthen Global Audio Partnership

Retrieved on: 
Thursday, December 7, 2023
Aston, ATC, COMMAND, Sound, Air traffic control, Formula, EPOS, Mission control center, Rain, Partnership, Communication, Noise, Environment, Management, C3

COPENHAGEN, Denmark, Dec. 7, 2023 /PRNewswire/ -- EPOS, today announces an extension and expansion of its partnership with the Aston Martin Aramco Cognizant F1® Team as Global Audio Partner.

Key Points: 
  • COPENHAGEN, Denmark, Dec. 7, 2023 /PRNewswire/ -- EPOS, today announces an extension and expansion of its partnership with the Aston Martin Aramco Cognizant F1® Team as Global Audio Partner.
  • Building on the existing collaboration, EPOS is expanding its technical partnership with the team.
  • "We moved the whole team into our new AMR Technology Campus in the spring, and it has been a significant positive change for the entire organization," said Mike Krack, Team Principal for the Aston Martin Aramco Cognizant Formula One® Team.
  • EPOS President, Jeppe Dalberg-Larsen comments, "With a unified ambition for unleashing human potential via technology, innovation, and state-of-the-art engineering – our partnership with Aston Martin Aramco Cognizant Formula One® Team is a natural fit.

BILLY GOAT® INTRODUCES NEW ENGINE OPTION ON THEIR SOD CUTTER LINEUP

Retrieved on: 
Wednesday, October 18, 2023
Sport, HP, Irrigation, Kohler, Golf, Maintenance, COMMAND, Honda, Torque, LEE, Electric motor

LEE'S SUMMIT, Mo., Oct. 18, 2023 /PRNewswire/ -- Billy Goat®, a brand of Briggs & Stratton®, is pleased to announce the new 200 cc Kohler® COMMAND PRO CV200 engine option on their 18" and 24" Sod Cutters.

Key Points: 
  • LEE'S SUMMIT, Mo., Oct. 18, 2023 /PRNewswire/ -- Billy Goat®, a brand of Briggs & Stratton®, is pleased to announce the new 200 cc Kohler® COMMAND PRO CV200 engine option on their 18" and 24" Sod Cutters.
  • Billy Goat's Hydro-Drive Sod Cutters, built upon the most rugged foundation in the industry, now offer the choice of Kohler's 9.5 ft-lbs of torque output for a high performing commercial power engine.
  • Offering effortless starts with the Easy-Pull™ technology and with a 3-year limited commercial warranty, you can rest assured that you will enjoy high-efficiency performance.
  • Billy Goat's Hydro-Drive Sod Cutters are an excellent choice for Golf / Muni / Sports Turf / Landscaping / Flatwork / Hardscape and Irrigation projects.

Synchron Completes Patient Enrollment for COMMAND Trial of Brain Computer Interface

Retrieved on: 
Tuesday, September 5, 2023
Technology, FDA, Health, Neurology, Other Science, Research, Physical Therapy, Medical Devices, Software, Health Technology, Hardware, Science, Data Management, Clinical Trials, University, SWITCH, BCI, BRAIN, FSIN, COMMAND, Clinical trial, Brain, Doctor of Philosophy, Paralysis, Blood, Motor cortex, FAHA, Patient, Journal of Neurology, Neurosurgery, and Psychiatry, Physician, Division, UPMC, IDE, Mount Sinai Health System, JAMA Neurology, NIH, Caregiver, Safety, Medical device, Engineering, Beckman Coulter, MD

Synchron , the endovascular brain-computer interface (BCI) company developing technology to restore functionality in patients with severe paralysis, today announced completion of patient enrollment in the US-based COMMAND trial.

Key Points: 
  • Synchron , the endovascular brain-computer interface (BCI) company developing technology to restore functionality in patients with severe paralysis, today announced completion of patient enrollment in the US-based COMMAND trial.
  • The early feasibility study assesses safety while evaluating quantified efficacy measures of the Synchron Switch™ motor neuroprosthesis in patients with severe paralysis.
  • The Synchron Switch brain computer interface is implanted in the blood vessel on the surface of the motor cortex of the brain via the jugular vein, through a minimally-invasive endovascular procedure.
  • Synchron published long-term safety results in JAMA Neurology from the SWITCH study that enrolled a total of four patients in Australia.

AbbVie Submits Regulatory Applications to FDA and EMA for Risankizumab (SKYRIZI®) in Ulcerative Colitis

Retrieved on: 
Monday, August 28, 2023
NORTH, Risankizumab, IBD, ABBV, COMMAND, Ulcerative colitis, EMA, Boehringer Ingelheim, Crohn's disease, INSPIRE, Patient, AbbVie, HEMI, European Medicines Agency, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NYSE, Food, Pharmaceutical industry, Safety

Safety results were generally consistent with the known safety profile of risankizumab, with no new safety risks observed1,2

Key Points: 
  • Safety results were generally consistent with the known safety profile of risankizumab, with no new safety risks observed1,2
    Risankizumab is an IL-23 inhibitor being evaluated as a treatment for adults with moderately to severely active ulcerative colitis and is currently approved by FDA and EMA in Crohn's disease, psoriatic arthritis and psoriasis1
    NORTH CHICAGO, Ill., Aug. 28, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications for a new indication to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for risankizumab (SKYRIZI®, 1200 mg intravenous [IV] [induction dose] and 180 mg and 360 mg subcutaneous [SC] [maintenance dose]) for the treatment of adult patients with moderately to severely active ulcerative colitis.
  • "While there has been advancement in therapies to treat ulcerative colitis, there is still an ongoing need for additional treatments to help those seeking relief from its disruptive effects," said Roopal Thakkar, M.D., senior vice president, development, regulatory affairs and chief medical officer, AbbVie.
  • "These submissions demonstrate our continued commitment to helping people living with IBD, and we look forward to providing a potential new treatment option for the management of ulcerative colitis."
  • Applications to the FDA and EMA are supported by data from two Phase 3 clinical trials: an induction study, INSPIRE, and a maintenance study, COMMAND.1,2 Significantly more patients treated with risankizumab 1200 mg IV at week 12 in the induction study and 180 mg or 360 mg SC at week 52 in the maintenance study achieved the primary endpoint of clinical remission (per Adapted Mayo Score), compared to patients receiving placebo.1,2 Additionally, more risankizumab-treated patients in both the induction and maintenance studies achieved the key secondary endpoints of endoscopic improvement (endoscopic subscore ≤1 without evidence of friability) and histologic endoscopic mucosal improvement (HEMI, defined as endoscopic subscore ≤1 without evidence of friability and Geboes score ≤3.1) compared to placebo.1,2
    The safety results in INSPIRE and COMMAND were generally consistent with the safety profile of risankizumab observed in previous studies across other indications, with no new safety risks observed.1,2
    Risankizumab (SKYRIZI) is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.

POLARIS EXPANDS ITS RANGER LINEUP WITH THE ALL-NEW RANGER XD 1500, AN ENTIRELY NEW CLASS OF EXTREME DUTY UTILITY SIDE-BY-SIDES

Retrieved on: 
Monday, July 31, 2023
Ride height, HD, Durability, Maintenance, GPS, Polaris, Air conditioning, Farmer, RIDE, COMMAND, Torque, USB, Table tennis rubber, Leg, Temperature, AM/FM, NorthStar, HVAC, LED, App, Engineering, Dust, Sun visor, Interior, Heat, Weather, Edition, Longevity, Family, MasterCraft, Rail transport, Transport, Hydraulic machinery, Electric motor, Heating, ventilation, and air conditioning, Road, Instrumentation, Satellite navigation device, Cassette tape, Shipbuilding

MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- Polaris Off Road, the global leader in powersports and off-road innovation, is once again breaking new ground with the industry's first extreme duty utility side-by-side: the all-new RANGER XD 1500. With its unprecedented capability, brute strength and unmatched comfort, the new extreme duty class of RANGER side-by-sides are engineered with the first-ever ProStar 1500cc 3-cylinder engine that offers an industry-leading 110 horsepower, the industry-exclusive STEELDRIVE automatic transmission for greater durability and precise control, and over 70 new accessories for enhanced customization, highlighted by Polaris' exclusive Lock & Ride MAX system. The RANGER XD 1500 establishes a new benchmark for utility side-by-sides.

Key Points: 
  • The RANGER XD 1500 delivers unprecedented capability for hard-working customers to haul more, tow more, and get more done in less time.
  • With the industry's only 1500cc utility engine, the RANGER XD 1500 provides over 30% more power and over 50% more torque than the next closest competitor.
  • 2024 RANGER XD 1500 NorthStar Premium:  Starting at US $39,999 / CAN $48,799
    The next step up is the RANGER XD 1500 NorthStar Premium.
  • The 2024 RANGER XD 1500 lineup is expected to begin shipping to dealers in late summer.

POLARIS CARVES A NEW PATH FOR SIDE-BY-SIDES & OUTDOOR ADVENTURE WITH POLARIS XPEDITION - A FIRST-OF-ITS-KIND ADVENTURE VEHICLE THAT ELEVATES OUTDOOR PURSUITS

Retrieved on: 
Tuesday, May 16, 2023
Acceleration, Adventure, Accessory, GPS, FOX, AMP, Atmosphere, All-terrain vehicle, ADV, RIDE, COMMAND, Utility, Suspension, XP, Temperature, Premium, Element, NorthStar, HVAC, Backcountry, Nature, Ultimate, Gear, MasterCraft, Heat, Comfort, Rail transport, Cassette tape, Hunting, Baggage, Landscape maintenance, Elevator mechanic, Borosilicate glass, Camping, Polaris

MINNEAPOLIS, May 16, 2023 /PRNewswire/ -- Polaris Off Road, the leader in off-road vehicle innovation, is once again driving the industry forward with a first-of-its-kind side-by-side platform – the all-new Polaris XPEDITION. The 2024 Polaris XPEDITION XP and ADV create an entirely new category of "adventure side-by-sides," combining the all-terrain capabilities of traditional side-by-sides with comfort and cargo capabilities typically associated with overlanding at the highest level.

Key Points: 
  • With the Polaris XPEDITION lineup, Polaris has created a new category of "adventure side-by-sides" – vehicles designed to enable and elevate the broadest range of specific outdoor pastimes and pursuits.
  • "We are driving our industry forward, once again, with innovation in the adventure side-by-side market to meet the needs of passionate adventurers."
  • 2024 Polaris XPEDITION XP Premium: Starting at US $28,999
    2024 Polaris XPEDITION ADV Premium: Starting at US $29,999
    *This trim will be made available in 2024.
  • 2024 Polaris XPEDITION XP NorthStar: Starting at US $38,999
    2024 Polaris XPEDITION ADV NorthStar: Starting at US $39,999
    Rounding out the lineup is the top-tier Polaris XPEDITION NorthStar.

INDIAN MOTORCYCLE DELIVERS SOPHISTICATED STYLE & BEST-IN-CLASS V-TWIN TOURING PERFORMANCE WITH NEW INDIAN PURSUIT ELITE, ANNOUNCES RETURN OF HIGHLY EXCLUSIVE CHIEFTAIN ELITE

Retrieved on: 
Tuesday, April 11, 2023
Smoke, GPS, Elite, Noise, Inertial measurement unit, RIDE, Apple Inc., Torque, COMMAND, Power, ABS, LED, Apple, Indian Powerplus, Ultimate, Honda 650cc standard and sport motorcycles, Weather, Pottery, Kerosene, Telescopic sight, Transport, Amusement park, Indian Motocycle Manufacturing Company, Motorcycle

MINNEAPOLIS, April 11, 2023 /PRNewswire/ -- Indian Motorcycle, America's First Motorcycle Company, today introduced the Indian Pursuit to its limited-edition Elite class of motorcycles and announced the return of its ultra-premium Chieftain Elite. Featuring premium componentry, each Elite model is crafted as the ultimate in American V-Twin style and exclusivity.

Key Points: 
  • Crafted as the Ultimate in American V-Twin Style & Exclusivity, Indian Pursuit Elite & Chieftain Elite Combine Eye-Catching Style with Premium Componentry
    MINNEAPOLIS, April 11, 2023 /PRNewswire/ -- Indian Motorcycle , America's First Motorcycle Company, today introduced the Indian Pursuit to its limited-edition Elite class of motorcycles and announced the return of its ultra-premium Chieftain Elite.
  • With only 150 units available worldwide, 2023 marks the debut for the Indian Pursuit Elite.
  • Known as the most capable and refined American touring machine on the road, the Indian Pursuit Elite offers sophisticated style and unparalleled comfort and performance.
  • of torque, the Indian Pursuit Elite delivers incredible V-twin touring performance with unmatched passing power.

Synchron to Begin Patient Enrollment for the COMMAND Trial of Brain-Computer Interface at Gates Vascular Institute

Retrieved on: 
Monday, March 20, 2023
Hardware, FDA, Health Technology, Technology, Nanotechnology, Surgery, Medical Devices, Neurology, Clinical Trials, Biotechnology, Science, Software, Other Science, Research, Health, Mobile, Wireless, Extremities, UB, Kaleida Health, University, Gates Vascular Institute, BCI, Jacobs School of Medicine and Biomedical Sciences, COMMAND, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, MBA, Brain, Biomedical sciences, CMO, Doctor of Philosophy, Computer, Jacobs Institute for Design Innovation, Trial of the century, Paralysis, Blood, Motor cortex, University of Pittsburgh Medical Center, Professor, MD, FAHA, Patient, Physician, SUNY, FACS, SUNY UB, EFS, IDE, Mount Sinai Health System, JAMA Neurology, Safety, Medical imaging, Medical device, Management, Medicine, Beckman Coulter, Neurosurgery

The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.

Key Points: 
  • The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.
  • The new site at Gates Vascular Institute marks the third approved COMMAND trial location, joining Mount Sinai Health System in New York and the University of Pittsburgh Medical Center.
  • The FDA granted Breakthrough Device designation to Synchron in August 2020 and an IDE in July 2021.
  • There is no guarantee of participation and principal investigators make the final determination of patient eligibility.

POLARIS UNLEASHES RZR PRO R FACTORY, INDUSTRY'S FIRST PURPOSE-BUILT, RACE-READY UTV

Retrieved on: 
Thursday, March 16, 2023
Heart, RIDE, DV, SCORE International, COMMAND, Radio, Peter Hancock (professor), UTV, Original equipment manufacturer, GPS, San Felipe 250, SAN, Shock, PCI, Evolution, Bead, Polaris RZR, FIA, RZR, Pro, SCORE, FOX, System, MasterCraft, Love, Desert, Rally raid, Cassette tape, Sparco, Polaris

MINNEAPOLIS, March 16, 2023 /PRNewswire/ -- Polaris Off Road, the leader in off-road vehicle innovation, today unveiled the industry's first purpose-built race-ready UTV – the RZR Pro R Factory. Based on its award-winning RZR Pro R platform, RZR Pro R Factory is specifically engineered to thrive against the grueling demands of open desert racing, providing a powerful centerpiece for its recently announced Polaris Factory Racing team.

Key Points: 
  • The Evolution of its Class-Leading RZR Pro R, All-New Polaris-Engineered Race UTV Features Race-Tuned Power, Desert-Proven Strength & Unmatched Control
    MINNEAPOLIS, March 16, 2023 /PRNewswire/ -- Polaris Off Road , the leader in off-road vehicle innovation, today unveiled the industry's first purpose-built race-ready UTV – the RZR Pro R Factory.
  • Based on its award-winning RZR Pro R platform, RZR Pro R Factory is specifically engineered to thrive against the grueling demands of open desert racing, providing a powerful centerpiece for its recently announced Polaris Factory Racing team.
  • Last year, the RZR Pro R demonstrated an elite combination of performance and durability when Brandon Sims captured the 2022 Baja 1000 UTV Overall.
  • At the wheel of each RZR Pro R Factory machine are Polaris RZR's new factory drivers Austin Weiland, Brock Heger and Cayden MacCachren.